Suh Sanggyun, Choi Soyeon, Choi YoungRok, Lee Boram, Cho Jai Young, Yoon Yoo-Seok, Han Ho-Seong
Department of Surgery, Chung-Ang University Gwangmyeong Hospital, Gwangmyeong, Korea.
Department of Pathology, Ulsan University Hospital, Ulsan, Korea.
Ann Hepatobiliary Pancreat Surg. 2023 Nov 30;27(4):372-379. doi: 10.14701/ahbps.23-058. Epub 2023 Sep 8.
BACKGROUNDS/AIMS: While single-incision laparoscopic cholecystectomy (SILC) has advantages in cosmesis and postoperative pain, its utilization has been limited. This study raises the possibility of expanding its indication to acute cholecystitis with the novel method of solo surgery under retrospective analysis.
We compared the outcomes of SILC (n = 58) to those of three-incision laparoscopic cholecystectomy (TILC; n = 117) for acute cholecystitis, being performed from March 2014 to December 2015.
Intraoperative results, including the operation time, did not differ significantly, except for drain catheter insertion ( = 0.004). Each group had 1 case of open conversion due to common bile duct injury. There was no significant difference in the length of hospital stay. Either group by itself was not a risk factor for complications, but in preoperative drainage for intraoperative perforation, 3 factors of intraoperative perforation, biliary complication, and history of upper abdominal operation for additional port, only American Society of Anesthesiology (ASA) scores for postoperative complication of Clavien-Dindo grades III and IV were significant risk factors.
Our study findings showed comparative outcomes between both groups, providing evidence for the safety and feasibility of SILC for acute cholecystitis.
背景/目的：虽然单孔腹腔镜胆囊切除术（SILC）在美观和术后疼痛方面具有优势，但其应用一直受到限制。本研究通过回顾性分析，探讨了采用新型单孔手术方法将其适应证扩大至急性胆囊炎的可能性。
我们比较了2014年3月至2015年12月期间进行的SILC（n = 58）和三孔腹腔镜胆囊切除术（TILC；n = 117）治疗急性胆囊炎的结果。
除引流管插入外（P = 0.004），包括手术时间在内的术中结果无显著差异。每组均有1例因胆总管损伤行开放手术转换。住院时间无显著差异。两组本身均不是并发症的危险因素，但在术中穿孔的术前引流、术中穿孔的3个因素、胆道并发症以及因额外端口进行上腹部手术的病史方面，只有美国麻醉医师协会（ASA）评分对于Clavien-Dindo III级和IV级术后并发症是显著的危险因素。
我们的研究结果显示了两组之间的比较结果，为SILC治疗急性胆囊炎的安全性和可行性提供了证据。
